Syros Pharmaceuticals, Inc.【SYRS】 利益剰余金の推移
機能の使い方
|
（単位：千ドル）
|
利益剰余金
|
前年比（％）
|
|
3Q24
|
-756,200
|
+14.9%
|
|
2Q24
|
-749,800
|
+21.3%
|
|
1Q24
|
-726,500
|
+24.8%
|
|
4Q23
|
-722,800
|
+29.5%
|
|
3Q23
|
-658,400
|
+19.0%
|
|
2Q23
|
-618,300
|
+18.2%
|
|
1Q23
|
-582,000
|
+19.1%
|
|
4Q22
|
-558,200
|
+20.4%
|
|
3Q22
|
-553,500
|
+25.9%
|
|
2Q22
|
-523,200
|
+26.5%
|
|
1Q22
|
-488,700
|
+24.9%
|
|
4Q21
|
-463,600
|
+23.0%
|
|
3Q21
|
-439,800
|
+26.8%
|
|
2Q21
|
-413,700
|
+26.4%
|
|
1Q21
|
-391,200
|
+26.1%
|
|
4Q20
|
-377,000
|
+28.7%
|
|
3Q20
|
-346,900
|
+27.0%
|
|
2Q20
|
-327,400
|
+29.2%
|
|
1Q20
|
-310,209
|
+32.6%
|
|
4Q19
|
-292,983
|
+34.7%
|
|
3Q19
|
-273,254
|
+37.0%
|
|
2Q19
|
-253,461
|
+37.9%
|
|
1Q19
|
-234,006
|
+37.9%
|
|
4Q18
|
-217,545
|
+40.1%
|
|
3Q18
|
-199,513
|
+42.5%
|
|
2Q18
|
-183,776
|
+45.7%
|
|
1Q18
|
-169,729
|
+50.5%
|
|
4Q17
|
-155,266
|
+53.3%
|
|
3Q17
|
-139,964
|
+55.0%
|
|
2Q17
|
-126,139
|
+65.7%
|
|
1Q17
|
-112,771
|
-
|
|
4Q16
|
-101,256
|
-
|
|
3Q16
|
-90,291
|
-
|
|
2Q16
|
-76,122
|
-
|